With the enactment of Pennsylvania’s new e-prescribing law, NACDS recognizes the leadership of State Rep. Tedd Nesbit (R), the bill’s prime sponsor; State Sen. Rich Alloway (R), sponsor of the Senate bill; Pennsylvania State Senate Majority Leader Jake Corman (R); Pennsylvania House of Representatives Majority Leader Dave Reed (R)
Arlington, Va. – The National Association of Chain Drug Stores (NACDS) is applauding the enactment of an electronic prescribing bill (HB 353) in Pennsylvania that will help to prevent opioid abuse. Pennsylvania Gov. Tom Wolf (D) signed the legislation yesterday.
The new law requires that all controlled substance prescriptions be electronically prescribed, with certain exceptions. The law takes effect October 24, 2019 – one year from the date of the Governor’s signature.
“Federal and state laws are aligning to more completely leverage e-prescribing as a way to help reduce fraud and abuse and thus to help keep opioids out of the wrong hands. Pennsylvania’s legislators at the federal and state level are contributing strongly to the advancement of e-prescribing as an important part of the solution.”
NACDS recognizes the leadership of State Rep. Tedd Nesbit (R), the bill’s prime sponsor; State Sen. Rich Alloway (R), sponsor of the Senate bill; Pennsylvania State Senate Majority Leader Jake Corman (R); Pennsylvania House of Representatives Majority Leader Dave Reed (R); and Governor Wolf. NACDS also thanked for their leadership the Pennsylvania Association of Chain Drug Stores, the Pennsylvania Orthopaedic Society, and the Pennsylvania District Attorneys Association.
“This legislation passed both chambers of the legislature unanimously with a true bipartisan effort, and with widespread support from stakeholders,” said NACDS President and CEO Steven C. Anderson, IOM, CAE. “NACDS applauds the leadership that has led to the enactment of this important strategy for opioid-abuse prevention.
“The advancement of e-prescribing is one of NACDS’ core public policy proposals to help address the opioid-abuse epidemic. NACDS’ proposals reflect pharmacists’ experiences on the front lines of healthcare delivery, and pharmacy’s ongoing commitment to a 100-percent commitment to patient care and a zero-tolerance for drug abuse.”
NACDS has long supported e-prescribing as part of the solution to the opioid abuse crisis and included it in its public policy recommendations earlier this year, along with ongoing pharmacy initiatives to prevent opioid abuse, including compliance programs; drug disposal; patient education; security initiatives; fostering naloxone access; stopping illegal online drug-sellers and rogue clinics; and more. Reflective of the journey toward greater use of electronic prescribing as a safeguard, NACDS was on the leading edge of working with the Drug Enforcement Administration to allow electronic prescribing of controlled substances. Until 2010, it was not even allowed.
Public support for e-prescribing is strong in Pennsylvania and across the nation. A poll conducted by Morning Consult and commissioned by NACDS in January 2018 found 76 percent of Pennsylvania voters support a requirement that all prescriptions must be handled electronically, rather than via paper or fax, as a way to help address the opioid abuse epidemic.
Thirteen states now have enacted an NACDS-backed mandate, including seven that have enacted such legislation this year. Legislation is pending in additional states as well.
Also yesterday, President Trump signed into law federal legislation – the SUPPORT for Patients and Communities Act (H.R. 6) – which includes the provisions of the NACDS-backed Every Prescription Conveyed Securely Act. The new federal law requires electronic prescribing for Schedule II through V controlled substances prescriptions covered under Medicare Part D to help prevent fraud, abuse and waste – with limited exceptions to ensure patient access. In another Pennsylvania connection for the effort to advance e-prescribing as part of the solution to the opioid-abuse epidemic, U.S. Sen. Pat Toomey (R-PA) was an original co-sponsor of the Every Prescription Conveyed Securely Act in the U.S. Senate.
“Federal and state laws are aligning to more completely leverage e-prescribing as a way to help reduce fraud and abuse and thus to help keep opioids out of the wrong hands. Pennsylvania’s legislators at the federal and state level are contributing strongly to the advancement of e-prescribing as an important part of the solution,” Anderson noted.